Celexa/Lexapro MDL winds up
Celexa/Lexapro MDL winds up
Introduction
The U.S. District Judge Nathaniel M. Gorton granted Forest Laboratories’ motion for summary judgment on all claims made by the plaintiffs who alleged that the company fraudulently promoted Celexa and Lexapro for pediatric depression. This ruling brings an end to the long-running Massachusetts MDL 2067: In Re: Celexa and Lexapro Marketing and Sales Practices Litigation.
Comments
Latest News
Pesticide Shield Bill Faces Long Odds in Missouri Senate
Categories: General
Legislation aimed at making it harder to sue pesticide manufacturers over cancer claims is facing a critical deadline, with an unusual coalition of opponents striving to stall its progress.
…Philips Sues CPAP Cleaner SoClean to Share Settlement Costs
Categories: Settlements
Philips has filed a lawsuit against SoClean, a company that manufactures ozone-based cleaning systems…
NJ Pharma Settles: Cash, Narcan for Delaware
Categories: Settlements
Amneal Pharmaceuticals, a New Jersey-based drug manufacturer, has reached a settlement agreement with Delaware and other states over its involvement in the…